EP2618825A4 - Verwendung von nigericin zur behandlung und vorbeugung von impfstoffvirusinfektionen - Google Patents

Verwendung von nigericin zur behandlung und vorbeugung von impfstoffvirusinfektionen

Info

Publication number
EP2618825A4
EP2618825A4 EP11827867.0A EP11827867A EP2618825A4 EP 2618825 A4 EP2618825 A4 EP 2618825A4 EP 11827867 A EP11827867 A EP 11827867A EP 2618825 A4 EP2618825 A4 EP 2618825A4
Authority
EP
European Patent Office
Prior art keywords
nigericin
treat
vaccinia virus
virus infections
prevent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11827867.0A
Other languages
English (en)
French (fr)
Other versions
EP2618825A1 (de
Inventor
Chad Myskiw
Jingxin Cao
Runtao He
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canada Minister of National Health and Welfare
Original Assignee
Canada Minister of National Health and Welfare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canada Minister of National Health and Welfare filed Critical Canada Minister of National Health and Welfare
Publication of EP2618825A1 publication Critical patent/EP2618825A1/de
Publication of EP2618825A4 publication Critical patent/EP2618825A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP11827867.0A 2010-09-21 2011-09-16 Verwendung von nigericin zur behandlung und vorbeugung von impfstoffvirusinfektionen Withdrawn EP2618825A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38477810P 2010-09-21 2010-09-21
PCT/CA2011/050567 WO2012040841A1 (en) 2010-09-21 2011-09-16 Use of nigericin to treat and prevent vaccinia virus infections

Publications (2)

Publication Number Publication Date
EP2618825A1 EP2618825A1 (de) 2013-07-31
EP2618825A4 true EP2618825A4 (de) 2014-04-09

Family

ID=45891760

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11827867.0A Withdrawn EP2618825A4 (de) 2010-09-21 2011-09-16 Verwendung von nigericin zur behandlung und vorbeugung von impfstoffvirusinfektionen

Country Status (3)

Country Link
EP (1) EP2618825A4 (de)
CA (1) CA2815706A1 (de)
WO (1) WO2012040841A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230312597A1 (en) * 2020-08-18 2023-10-05 Council Of Scientific And Industrial Research (An Indian Registered Body Incorporated Under The Regn Novel compounds with antibacterial and anti viral activities

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0294538A2 (de) * 1987-06-11 1988-12-14 S O "Pharmachim" Verwendung von Nigerizin zur Herstellung eines Mittels zur Behandlung von Virus-Erkrankungen
AU2836289A (en) * 1988-01-12 1989-07-13 Hoechst Aktiengesellschaft Nigericin derivatives, processes for their preparation, agents containing these compounds and the use thereof, and the use of nigericin as an antiviral substance

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3995027A (en) * 1975-06-04 1976-11-30 Eli Lilly And Company Anti-viral method in animals

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0294538A2 (de) * 1987-06-11 1988-12-14 S O "Pharmachim" Verwendung von Nigerizin zur Herstellung eines Mittels zur Behandlung von Virus-Erkrankungen
AU2836289A (en) * 1988-01-12 1989-07-13 Hoechst Aktiengesellschaft Nigericin derivatives, processes for their preparation, agents containing these compounds and the use thereof, and the use of nigericin as an antiviral substance

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BERHANU AKLILE ET AL: "ST-246 inhibits in vivo poxvirus dissemination, virus shedding, and systemic disease manifestation.", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY DEC 2009, vol. 53, no. 12, December 2009 (2009-12-01), pages 4999 - 5009, XP055102627, ISSN: 1098-6596, DOI: 10.1128/AAC.00678-09 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1983, PANCHEVA S: "EFFECT OF THE ANTIBIOTIC A-23187 CALCIMYCIN ON THE REPRODUCTION OF SOME VIRUSES IN CELL CULTURES", XP002720423, Database accession no. PREV198477049594 *
KERN EARL R: "In vitro activity of potential anti-poxvirus agents.", ANTIVIRAL RESEARCH JAN 2003, vol. 57, no. 1-2, January 2003 (2003-01-01), pages 35 - 40, XP055102033, ISSN: 0166-3542, DOI: 10.1016/S0166-3542(02)00198-5 *
PANCHEVA S: "EFFECT OF THE ANTIBIOTIC A-23187 CALCIMYCIN ON THE REPRODUCTION OF SOME VIRUSES IN CELL CULTURES", ACTA MICROBIOLOGICA BULGARICA, vol. 13, 1983, pages 29 - 32, ISSN: 0204-8809 *
See also references of WO2012040841A1 *

Also Published As

Publication number Publication date
CA2815706A1 (en) 2012-04-05
WO2012040841A1 (en) 2012-04-05
EP2618825A1 (de) 2013-07-31

Similar Documents

Publication Publication Date Title
HRP20180972T1 (hr) Kombinacija fenoksibenzamina i polimiksina e za liječenje mikrobnih infekcija
ZA201302979B (en) Dianosis and treatment relating to th2 inhibition
EP2827869A4 (de) Zusammensetzungen und verfahren zur verbesserung des therapeutischen nutzens von indirubin und analoga davon, mit meisoindigo
EP2491033A4 (de) Azaindazole zur behandlung von flaviviridae-virusinfektionen
EP2611413A4 (de) Hautzusammensetzungen und verwendungsverfahren dafür
GB201302653D0 (en) Pharmaceutical compositions and methods of treatment
HK1185552A1 (en) Use of interleukin-22 in treating viral hepatitis -22
HK1210187A1 (en) Compositions and methods related to prevention and treatment of rabies infection
ZA201209411B (en) Vaccine and methods to reduce campylobacter infection
PL2534150T3 (pl) Sposoby leczenia infekcji wirusowej
EP2568892A4 (de) Vorrichtungen und verfahren zur behandlung von gallensteinen
HK1176936A1 (en) Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof
BR112013014915A2 (pt) composição curativa e métodos de tratamento
ZA201408057B (en) Compositions and methods for the treatment of moderate to severe pain
EP2701712A4 (de) Verwendung von uridin und desoxyuridin zur behandlung folat-vermittelter krankheiten
EP2650292A4 (de) Thiazolaminderivat und seine verwendung als medikament gegen picornaviridae-infektionen
RS55027B1 (sr) Upotreba sredstva za siliranje za tretiranje neusitnjene repe
EP2618825A4 (de) Verwendung von nigericin zur behandlung und vorbeugung von impfstoffvirusinfektionen
PL2374461T3 (pl) Piroksykam do profilaktycznego i terapeutycznego leczenia zakażeń opryszczką
EP2558117A4 (de) Expression von im positiven sinne einsträngigen rna-viren und verwendungen davon
GB201012168D0 (en) Treatment of viral infections
GB201001821D0 (en) Treatment of viral infections
ITTO20110635A1 (it) Composizione farmaceutica di combinazione e metodi per trattare e prevenire le malattie infettive
HK1198742A1 (en) Prevention and treatment of hiv infection hiv
AU2011902348A0 (en) Novel treatment and prevention of dog viral infections

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20130422

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/35 20060101AFI20140225BHEP

Ipc: A61P 31/20 20060101ALI20140225BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20140306

17Q First examination report despatched

Effective date: 20151006

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160217